Platinum-based chemotherapy is a standard treatment for ovarian cancer, but its effectiveness can be limited in some cases.

Women with a certain type of ovarian cancer may benefit from taking a drug used to treat a rare disease, a new study has ...

Respiratory and lung cancer risks are not linked to asbestos-free talc exposure. While some data is inconclusive, no ...

Letrozole monotherapy did not demonstrate noninferiority compared with chemotherapy plus letrozole for patients with ovarian cancer.

A drug for a rare disease may extend the lives of ovarian cancer patients, a new trial has suggested. Patients with a certain ...

In a systematic review and meta-analysis, researchers found that occupational exposure to talc that is not contaminated with ...

Late breaking results from the phase III NRG GY019 trial indicate that letrozole monotherapy (L) did not demonstrate non ...

Fast Track status enables closer FDA engagement to potentially accelerate development of a CDH6-directed ADC in ...

Speaking to Fierce at the European Society for Medical Oncology (ESMO) Congress in Berlin at the time, GSK’s Hesham Abdullah, ...

A newly identified interaction between ovarian cancer cells and surrounding abdominal cells helps explain the cancer’s ...

Eli Lilly's acquisition spree shows no sign of stalling, although the Big Pharma is keeping the terms of its latest buy ...

Keytruda drug is approved for a wide range of solid tumors and blood cancers, often for cases that are advanced, metastatic ...